Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira‐Silva, Gwen Falony, Eugeni Belda, et al.
Nature (2020) Vol. 581, Iss. 7808, pp. 310-315
Open Access | Times Cited: 373

Showing 51-75 of 373 citing articles:

Predicting drug-microbiome interactions with machine learning
Laura E. McCoubrey, Simon Gaisford, Mine Orlu, et al.
Biotechnology Advances (2021) Vol. 54, pp. 107797-107797
Open Access | Times Cited: 62
Diet-gut microbiota interactions on cardiovascular disease
Xufei Zhang, Philippe Gérard
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1528-1540
Open Access | Times Cited: 59
NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
David Niederseer, Bernhard Wernly, Elmar Aigner, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 467-467
Open Access | Times Cited: 58
Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome
Xiaomin Hu, Hanyu Li, Xinyue Zhao, et al.
Theranostics (2021) Vol. 11, Iss. 12, pp. 5778-5793
Open Access | Times Cited: 57
Variation and transmission of the human gut microbiota across multiple familial generations
Mireia Vallès-Colomer, Rodrigo Bacigalupe, Sara Vieira‐Silva, et al.
Nature Microbiology (2021) Vol. 7, Iss. 1, pp. 87-96
Open Access | Times Cited: 56
The Metabolic Role and Therapeutic Potential of the Microbiome
Louise E. Olofsson, Fredrik Bäckhed
Endocrine Reviews (2022) Vol. 43, Iss. 5, pp. 907-926
Open Access | Times Cited: 52
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Increasing the diversity of dietary fibers in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk
Harimalala Ranaivo, Florence Thirion, Christel Béra‐Maillet, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Heterogeneity in statin responses explained by variation in the human gut microbiome
Tomasz Wilmanski, Sergey A. Kornilov, Christian Diener, et al.
Med (2022) Vol. 3, Iss. 6, pp. 388-405.e6
Open Access | Times Cited: 44
The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
Zarina Ebrahim, Sebastian Proost, Raúl Y. Tito, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 805-805
Open Access | Times Cited: 39
Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
Brandon Flaig, Rachel Garza, Bhavdeep Singh, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 228-228
Open Access | Times Cited: 31
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease
Clara Caenepeel, Gwen Falony, Kathleen Machiels, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 483-495
Open Access | Times Cited: 30
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
Chi L. Nguyen, Kate A. Markey, Oriana Miltiadous, et al.
Cell (2023) Vol. 186, Iss. 12, pp. 2705-2718.e17
Closed Access | Times Cited: 28
Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review
L.R. Caley, H. White, Marcus C. de Goffau, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 5, pp. 1797-1814
Closed Access | Times Cited: 24
The Role of Lifestyle and Dietary Factors in the Development of Premature Ovarian Insufficiency
Andrew N. Shelling, Noha Ahmed Nasef
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1601-1601
Open Access | Times Cited: 23
Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide
Petros Andrikopoulos, Judith Aron‐Wisnewsky, Rima Chakaroun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Targeting the human gut microbiome with small-molecule inhibitors
Amelia Y. M. Woo, Miguel A. Aguilar Ramos, Rohan Narayan, et al.
Nature Reviews Chemistry (2023) Vol. 7, Iss. 5, pp. 319-339
Closed Access | Times Cited: 22
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy
Michinari Nakamura
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access | Times Cited: 13
Examining the healthy human microbiome concept
Raphaela Joos, Katy Boucher, Aonghus Lavelle, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 13
Oral-gut microbial transmission promotes diabetic coronary heart disease
Yiwen Li, Yanfei Liu, Jing Cui, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action
Shiqin Zhang, Xiaoling Ren, Bingzheng Zhang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1859-1859
Open Access | Times Cited: 12
Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies
Mahmoud G. El Baassiri, Zachariah Raouf, Sarah Badin, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Targeting the Gut Microbiome to Treat Cardiometabolic Disease
Panagiotis Theofilis, Panayotis K. Vlachakis, Evangelos Oikonomou, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 2, pp. 25-34
Closed Access | Times Cited: 10
Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
Kirti Garg, M. Hasan Mohajeri
Brain Research Bulletin (2024) Vol. 207, pp. 110883-110883
Open Access | Times Cited: 10
High-throughput transcriptomics of 409 bacteria–drug pairs reveals drivers of gut microbiota perturbation
Deirdre Ricaurte, Yiming Huang, Ravi U. Sheth, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 561-575
Open Access | Times Cited: 9

Scroll to top